| Literature DB >> 33126758 |
Nadezhda E Ustyuzhanina1, Maria I Bilan1, Andrey S Dmitrenok1, Alexandra S Silchenko2, Boris B Grebnev2, Valentin A Stonik2, Nikolay E Nifantiev1, Anatolii I Usov1.
Abstract
FucosylatedEntities:
Keywords: Holothuria hilla; Paracaudina chilensis; anticoagulant activity; fucosylated chondroitin sulfate; sea cucumber
Mesh:
Substances:
Year: 2020 PMID: 33126758 PMCID: PMC7693656 DOI: 10.3390/md18110540
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Percentages of crude polysaccharide preparations and composition of fucosylated chondroitin sulfates PC and HH (in w/w %).
| Polysaccharide | Yield | Fuc | GlcA | SO3Na | GlcN | GalN | Gal |
|---|---|---|---|---|---|---|---|
|
| 16.1 | 10.8 | 13.3 | 21.2 | - | 10.7 | 1.6 |
|
| 20.9 | 10.9 | 11.4 | 21.3 | 1.2 | 8.8 | 4.3 |
Figure 1The 13C NMR spectra of the fucosylated chondroitin sulfates PC and HH.
Figure 2Fragments of 1H NMR spectra of the fucosylated chondroitin sulfates PC and HH.
Figure 3Repeating blocks of fucosylated chondroitin sulfates PC (units A–D, F) and HH (units A–J). Unit A bears Fuc2S4S (D), whereas unit A’ bears Fuc3S4S (E) or Fuc4S (F).
Figure 4The HSQC NMR spectra of polysaccharides PC (A) and HH (B).
Chemical shifts of the signals in the 1H and 13C NMR spectra of the fucosylated chondroitin sulfates PC and HH (the bold numerals indicate the positions of sulfate).
| Residue | H1/C1 | H2/C2 | H3/C3 | H4/C4 | H5/C5 | H6/C6 |
|---|---|---|---|---|---|---|
| 4.48/ | 3.64/ | 3.72/ | 3.96/ | 3.70/ | - | |
| 4.48/ | 3.60/ | 3.68/ | 4.00/ | 3.71/ | - | |
| 4.58/ | 4.07/ | 3.95/ |
| 4.00/ |
| |
| 4.58/ | 4.07/ | 3.95/ |
| 4.02/ | 3.81/ | |
| 5.68/ |
| 4.17/ |
| 4.90/ | 1.37/ | |
| 5.34/ | 3.95/ |
|
| 4.80/ | 1.37/ | |
| 5.40/ | 3.82/ | 4.04/ |
| 4.80/ | 1.37/ | |
| 4.47/ | 3.38/ | 3.59/ |
| 4.02/ | 3.81/ | |
| 5.28/ | 4.28/ | 4.00/ |
| NdNd | 1.37/ | |
| 5.41/ | 4.19/ |
|
| NdNd | 1.37/ |
Nd—not determined.
Figure 5Anticoagulant activity of polysaccharides PC (blue), HH (red), CD (orange), heparin (black), and enoxaparin (dotted line). (A) Activate partial thromboplastin time (APTT) assay, (B) anti-IIa-activity in the presence of antithrombin III (ATIII), (C) anti-Xa-activity in the presence of ATIII, and (D) anti-IIa-activity without ATIII. n = 4, p < 0.05.